Clinical Trials Directory

Trials / Completed

CompletedNCT04871243

Children Vaccination From 11 to 14 Years Old

Qualitative Study Evaluating Opinions Regarding HPV Vaccinnation in Boys' Parents Aged From 11 to 14 Years Old

Status
Completed
Phase
Study type
Observational
Enrollment
18 (actual)
Sponsor
Centre Hospitalier Eure-Seine · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The human papilloma virus infection is the most frequent sexually transmitted infection around the world. In the vast majority of cases, these are inapparent infections that disappear spontaneously. In some cases, the HPV infection persists and can generate anogenital warts or cancer. In France, the papillomavirus is responsible for 6000 new cases of cancer/year with several possible localizations : cervical, anal, penile, oropharyngeal, vulvar or vaginal. Among them, 4580 new cases of cancer/year occur in women, and half of them are diagnosis of cervical cancer. A quarter of cancers caused by papillomavirus occur in men. In France, the commercialization of anti-HPV vaccine in 2007 was addressed only to girls, in order to gain a group immunity that would therefore protect the boys. This vaccination did not achieve the cover immunization target that were announced: the objective was fixed at 60% of vaccination coverage and at the end of 2018, only 24% was achieved on the complete vaccination schedule. In December 2019, the French National Authority for Health recommended the anti-HPV vaccinations in girls and boys.

Detailed description

This qualitative study evaluates parents' opinion regarding the vaccination and the HPV. Parent's eligible to participate in this study are those with boys between 11 and 14 years old. The anti-HPV vaccination is perceived favorably in 38% of parents, but 42% of parents are undecided. The investigators would like to evaluate qualitatively the opinions and the obstacles in this vaccination, using interviews in parents of boys aged between 11 and 14 years old.

Conditions

Interventions

TypeNameDescription
OTHERQualitative InterviewIndividual semi-structured interviews

Timeline

Start date
2021-05-01
Primary completion
2022-02-11
Completion
2022-02-11
First posted
2021-05-04
Last updated
2022-04-22

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04871243. Inclusion in this directory is not an endorsement.

Children Vaccination From 11 to 14 Years Old (NCT04871243) · Clinical Trials Directory